Hakutulokset - Andy I. Chen

  • Näytetään 1 - 13 yhteensä 13 tuloksesta
Tarkenna hakua
  1. 1
    Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience

    Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience Tekijä Andy I. Chen, Alex McMillan, Robert S. Negrin, Sandra J. Horning, Ginna G. Laport

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation

    Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation Tekijä Ruth S. S. Arestides, Hongzhen He, Robert M. Westlake, Andy I. Chen, Arlene H. Sharpe, David L. Perkins, Patricia W. Finn

    Julkaistu 2002
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Ox40-Ligand Has a Critical Costimulatory Role in Dendritic Cell:T Cell Interactions

    Ox40-Ligand Has a Critical Costimulatory Role in Dendritic Cell:T Cell Interactions Tekijä Andy I. Chen, Alexander J. McAdam, Janet E. Buhlmann, Sumi Scott, Mark Lupher, Edward Greenfield, Peter Baum, William C. Fanslow, David M. Calderhead, Gordon J. Freeman, Arlene H. Sharpe

    Julkaistu 1999
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

    Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study Tekijä Hervé Tilly, Franck Morschhauser, Nancy L. Bartlett, Amitkumar Mehta, Gilles Salles, Corinne Haïoun, Javier Muñoz, Andy I. Chen, Kathryn S. Kolibaba, Dan Lü, Mark Yan, Elicia Penuel, Jamie Hirata, Calvin Lee, Jeff P. Sharman

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

    Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse Tekijä Craig H. Moskowitz, Jan Walewski, Auayporn Nademanee, Tamás Masszi, Edward Agura, Jerzy Hołowiecki, Muneer H. Abidi, Andy I. Chen, Patrick J. Stiff, Simonetta Viviani, Veronika Bachanová, Anna Sureda, Teresa McClendon, Connie Lee, Julie Lisano, John Sweetenham

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL

    First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL Tekijä John C. Byrd, Stephen D. Smith, Nina D. Wagner‐Johnston, Jeff P. Sharman, Andy I. Chen, Ranjana H. Advani, Bradley Augustson, Paula Marlton, S. Renee Commerford, Kwame Okrah, Lichuan Liu, Elaine Murray, Elicia Penuel, Ashley F. Ward, Ian W. Flinn

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Optimizing the Post-CAR T Monitoring Period for Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel

    Optimizing the Post-CAR T Monitoring Period for Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel Tekijä Nausheen Ahmed, William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanová, Loretta J. Nastoupil, Miguel‐Angel Perales, Richard T. Maziarz, Jamie Brower, Gunjan L. Shah, Andy I. Chen, Olalekan O. Oluwole, Stephen J. Schuster, Michael Bishop, Joseph P. McGuirk, Peter A. Riedell

    Julkaistu 2024
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

    Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomise... Tekijä Craig H. Moskowitz, Auayporn Nademanee, Tamás Masszi, Edward Agura, Jerzy Hołowiecki, Muneer H. Abidi, Andy I. Chen, Patrick J. Stiff, Alessandro M. Gianni, Angelo Michele Carella, Dzhelil Osmanov, Veronika Bachanová, John Sweetenham, Anna Sureda, Dirk Huebner, Eric L. Sievers, Andy Chi, Emily K. Larsen, Naomi Hunder, Jan Walewski

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

    Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS) Tekijä Franck Morschhauser, Ian W. Flinn, Ranjana H. Advani, Laurie H. Sehn, Catherine Diefenbach, Kathryn S. Kolibaba, Oliver W. Press, Gilles Salles, Hervé Tilly, Andy I. Chen, Sarit Assouline, Bruce D. Cheson, Martin Dreyling, Anton Hagenbeek, Pier Luigi Zinzani, Surai Jones, Ji Cheng, Dan Lü, Elicia Penuel, Jamie Hirata, Michael Wenger, Yu-Waye Chu, Jeff P. Sharman

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

    Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma Tekijä Michael Scordo, Jessica Flynn, Mithat Gönen, Sean M. Devlin, Allison Parascondola, Ana Alarcón Tomás, Roni Shouval, Jamie Brower, David L. Porter, Stephen J. Schuster, Veronika Bachanová, Joseph E. Maakaron, Richard T. Maziarz, Andy I. Chen, Loretta J. Nastoupil, Joseph P. McGuirk, Olalekan O. Oluwole, Andrew Ip, Lori A. Leslie, Michael R. Bishop, Peter A. Riedell, Miguel‐Angel Perales

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation

    Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation Tekijä Mehdi Hamadani, Parameswaran Hari, Ying Zhang, Jeanette Carreras, Görgün Akpek, Mahmoud Aljurf, Ernesto Ayala, Veronika Bachanová, Andy I. Chen, Yi‐Bin Chen, Luciano J. Costa, Timothy S. Fenske, César O. Freytes, Siddhartha Ganguly, Mark Hertzberg, Leona Holmberg, David J. Inwards, Rammurti T. Kamble, Edward Kanfer, Hillard M. Lazarus, David I. Marks, Taiga Nishihori, Richard F. Olsson, Nishitha Reddy, David A. Rizzieri, Bipin N. Savani, Melhem Solh, Julie M. Vose, Baldeep Wirk, David G. Maloney, Sonali M. Smith, Silvia Montoto, Wael Saber

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis

    Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis Tekijä Carla Casulo, Jonathan W. Friedberg, Kwang Woo Ahn, Christopher R. Flowers, Alyssa DiGilio, Sonali M. Smith, Sairah Ahmed, David J. Inwards, Mahmoud Aljurf, Andy I. Chen, Hannah Choe, Jonathon B. Cohen, Edward A. Copelan, Umar Farooq, Timothy S. Fenske, César O. Freytes, Sameh Gaballa, Siddhartha Ganguly, Yogesh Jethava, Rammurti T. Kamble, Vaishalee P. Kenkre, Hillard M. Lazarus, Aleksandr Lazaryan, Richard F. Olsson, Andrew R. Rezvani, David A. Rizzieri, Sachiko Seo, Gunjan L. Shah, Nina Shah, Melham Solh, Anna Sureda, Basem M. William, Aaron Cumpston, Andrew D. Zelenetz, Brian K. Link, Mehdi Hamadani

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

    Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update Tekijä Martin Dreyling, Nathan Fowler, Michael Dickinson, Joaquín Martínez‐López, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chávez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A. Riedell, P. Joy Ho, José Antonio Pérez‐Simón, Andy I. Chen, Loretta J. Nastoupil, Bastian von Tresckow, Andrés J.M. Ferreri, Takanori Teshima, Piers Patten, Joseph P. McGuirk, Andreas Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Zinzani, Ram Malladi, Inès Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O’Donovan, Roberto Ramos, Harald J. Maier, Aisha Masood, Catherine Thiéblemont, Stephen J. Schuster

    Julkaistu 2024
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: